腫瘍学における老化をターゲットに:がんに対する新たな治療法
Satoru Meguro1, Syunta Makabe1, Kei Yaginuma1
1Department of Urology, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
Current oncology (Toronto, Ont.)
|August 27, 2025
まとめ
細胞の衰えは 老化に繋がるプロセスで 癌には2つの役割があります 衰老細胞を老化治療薬で 標的とした治療は 特に老化誘発療法と組み合わせた治療は 将来の癌治療に 有望な結果を示しています
科学分野:
- 腫瘍学
- 細胞生物学
- ゲロントロジー
背景:
- 細胞の老化は 老化と癌の発生と密接に関連しています
- 衰老は増殖を止めることで腫瘍抑制剤として作用し,また分泌因子や細胞表面の変化を通じて癌を促進します.
- 腫瘍の微小環境にある老化細胞は 繊維芽細胞,内皮細胞,免疫細胞を含む がん進行を促すことができる.
研究 の 目的:
- 癌における 細胞老化の多面的な役割を探るため
- 治療による老化ががんに与える影響を検討する.
- 癌治療の新たな戦略として 老年療法薬の可能性を議論する.
主な方法:
- 癌における細胞老化に関する研究の文献レビュー.
- 腫瘍抑制と促進における老化の二重の役割の分析.
- 老化治療薬と老化誘発療法との組み合わせの検討
主要な成果:
- 衰老はパラドックスな効果を示し,増殖を抑制しながら,潜在的にパラクリンシグナル伝達と表面プロテオームの変化を通じて腫瘍の成長を促進します.
- 治療による衰老は,がん治療の効果と結果に影響を与える可能性があります.
- セノセラピーは 有望な治療法として現れており 臨床試験も進行中です
結論:
- 細胞の老化は 癌の生物学の重要な要因で 複雑に絡み合っています
- セネセプティクスは,特に老化誘導戦略と組み合わせると,がんに対する治療アプローチの発展を表しています.
- 臨床腫瘍学における老年治療の応用を最適化するためにさらなる研究が必要である.
関連する概念動画
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:15Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K